Canopy Growth (CGC) Total Debt (2017 - 2026)
Canopy Growth (CGC) posted Total Debt of $170.2 million for Q1 2026, up 5.47% sequentially from $161.3 million in Q4 2025, and down 19.7% YoY from $211.9 million in Q1 2025.
Canopy Growth (CGC) Total Debt (2017 - 2026) Analysis & Trends
Canopy Growth has reported Total Debt for 10 years, with the latest figure at $170.2 million in Q1 2026.
- Quarterly Total Debt fell 19.7% year-over-year to $170.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $170.2 million (down 19.7% YoY) and the FY2026 annual result came in at $170.2 million, down 19.7% from the prior year.
- Total Debt climbed to $170.2 million in Q1 2026 per CGC's latest filing, from $161.3 million in the prior quarter.
- Over five years, Total Debt peaked at $1.2 billion in Q1 2022 and troughed at $161.3 million in Q4 2025.
- A 5-year average of $556.2 million and a median of $443.2 million in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2022 and 2025: Total Debt fell 5.25% in 2022, then plunged 59.16% in 2025.
- Over 5 years, Total Debt stood at $888.2 million in 2022, then slumped by 49.38% to $449.6 million in 2023, then decreased by 29.69% to $316.1 million in 2024, then tumbled by 48.96% to $161.3 million in 2025, then grew by 5.47% to $170.2 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $170.2 million, $161.3 million, and $165.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 760.00 Mn |
| 10 | Canopy Growth | 441.27 Mn | 194.25 Mn | 16.08 Mn | 173.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 173.65 Mn |
| Mar 31, 2026 | 170.17 Mn |
| Dec 31, 2025 | 161.34 Mn |
| Sep 30, 2025 | 165.80 Mn |
| Jun 30, 2025 | 213.12 Mn |
| Mar 31, 2025 | 211.91 Mn |
| Dec 31, 2024 | 316.10 Mn |
| Sep 30, 2024 | 406.00 Mn |
| Jun 30, 2024 | 410.13 Mn |
| Mar 31, 2024 | 443.21 Mn |
| Dec 31, 2023 | 449.59 Mn |
| Sep 30, 2023 | 508.12 Mn |
| Jun 30, 2023 | 777.98 Mn |
| Mar 31, 2023 | 966.70 Mn |
| Dec 31, 2022 | 888.17 Mn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 1.18 Bn |
| Dec 31, 2021 | 1.20 Bn |
| Sep 30, 2021 | 1.21 Bn |